id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2026-N-0707-0001,FDA,FDA-2026-N-0707,"GlaxoSmithKline; Withdrawal of Approval of a New Drug Application for Wellcovorin (Leucovorin Calcium) Tablets, EQ 5 mg Base and EQ 25 mg Base",Notice,Withdrawal,2026-04-10T04:00:00Z,2026,4,2026-04-10T04:00:00Z,,2026-04-10T17:40:29Z,2026-06911,0,0,09000064b926837d